Physician profile
Ashley Davila
NPI 1326054016
$1,266.46
in general payments reported to CMS, 2019-2025
17 companies · $662 in 2025
The $662 reported for 2025 was more than what 86% of Medical-Surgical (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $106 · 2023: $123 · 2024: $250 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995 · Education: $40.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.97 |
| Education | $40.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $340.42 | 2024-2025 | Rezlidhia, Tavalisse, Gavreto |
| Amgen INC. | $234.95 | 2021-2025 | Repatha, Tepezza, Evenity |
| Abbott Laboratories | $152.91 | 2024-2025 | Freestyle Libre 3, Proclaim |
| Novartis Pharmaceuticals Corporation | $129.83 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $125.98 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $44.71 | 2024-2025 | |
| Abbvie INC. | $37.93 | 2022-2023 | |
| Novo Nordisk INC | $36.85 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Kyowa Kirin, INC. | $29.50 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.22 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $21.51 | 2024 | Keytruda |
| Corcept Therapeutics | $19.96 | 2024 | Korlym |
| Ascensia Diabetes Care US INC. | $16.32 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $14.38 | 2024 | Lokelma |
| Cequr Corporation | $13.80 | 2023 | Cequr Simplicity |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $11.70 | 2021 | |
| Medtronic, INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Davila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.